Skip to main content

Market Overview

Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'

Share:
Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he is staying with U.S. 1 Year Treasury Bill, which has over 5% yield.

Jim Lebenthal of Cerity Partners picked CVS Health Corporation (NYSE: CVS), which is scheduled to hold Investor Day on Dec. 5, 2023.

On Nov. 1, CVS Health said third-quarter sales increased 10.6% Y/Y to $89.76 billion, beating the consensus of $88.25 billion.

Don’t forget to check out our premarket coverage here

Sarat Sethi named Morgan Stanley (NYSE: MS) as his final trade amid a pickup in market activity.

Morgan Stanley appointed its co-president, Edward (Ted) Pick, as chief executive officer, effective Jan. 1.

Liz Young of BNY Mellon Investment Management picked Invesco Food & Beverage ETF (NYSE: PBJ).

Price Action: CVS Health shares closed at $68.48 on Monday, while Morgan Stanley gained 0.4% to $81.21. Invesco Food & Beverage ETF gained 0.7% during Monday’s session.
Check This Out: How To Earn $500 A Month From Dell Stock Following Last Week's Upbeat Earnings

Image: Pixabay

 

Related Articles (CVS + MS)

View Comments and Join the Discussion!

Posted-In: CNBC Halftime Report Final TradesLong Ideas News Top Stories Markets Media Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com